Embed Size (px)
Citation preview
Q1 Report March 31, 2015
Investors presentation
May 29, 2015
Confidentiality
This presentation has been prepared by Marcolin S.p.A. and its affiliates. The information contained
herein is confidential and has been prepared solely for the needs of the adressee and is not to be relied
upon by any other person or entity. Hence, if you wish to disclose copies of this report to any other
person or entity, you must inform they that they may not use these reports for any purpose without
Marcolin written consent.
No representation, warranty or undertaking, express or implied, is made as to, and no reliance shoud be
placed on, the fairness, accuracy, completeness or correctness of the information or the opinions
contained herein.
2
3
At a glance
Key consolidated financials: LTM
Viva Integration Project
Agenda
Appendix
Key consolidated financials: Q1 2015
At a glance Key facts 2015
> Project Fortogna
> Portfolio licences
4
> Joint ventures
5
At a glance
Key consolidated financials: LTM
Viva Integration Project
Agenda
Appendix
Key consolidated financials: Q1 2015
Key consolidated financials
* EBITDA is affected by a number of extraordinary items. For this reason it has been adjusted to restate the one-off effects deriving from the re-organization as
represented in “Consolidated Adjusted EBITDA” page.
Sales Consolidated Net sales increased +16,4% vs. PY; +5,5% at constant FX.
Mainly driven by TF (+€ 6.4m), GU (+€3,0m), TB (+€ 1.5m) and the EZ contribution for
€4,0m.
114.9 Million EUR
EBITDA 2015 Q1 EBITDA Reported is € 9,0m (€ 9.8m previous year).
2015 Q1 Adjusted EBITDA* (excluding one-offs) is € 15,2m or 13.2% (€ 11.4m PY).
LTM Adjusted Run-Rate EBITDA for 2015 is € 51.6m or 13.6% on Net sales.
FY 15,2 13.2% On Net
sales
Net Debt
104.1 2015 Constant FX
6
Consolidated Net Debt as of March 2015 is € 220.2m (€ 196,1m end of
December 2014), growing €24,1m vs. PY mostly due to Trade Working Capital
increase (Inventory and Trade Receivables).
The ratio Net financial position to LTM Adjusted Run-rate EBITDA is 4.14.
Million EUR in 2014
98.7
4.14 NFP /
Adj LTM RR Ebitda
FY 51,6 13.6% On Net
sales
220.2 Million EUR
YTD Q1 Consolidated Sales 114.9 million EUR
2015 YTD Q1
@ const FOREX
+16.4% vs PY
Global sales By market destination
104.1 mill EUR +5.5% vs PY
7
North America
Europe Asia
RoW
52.2 Mill. EUR
32.7 Mill. EUR
10.0 Mill. EUR
20.0 Mill. EUR
45.4%
28.4% 8.7%
17.4%
+2.0%
+31.7%
+7.2%
+13.1%
• Net Sales performance was positive: +€16.2m (+16.4%) above last year, driven by full recovery of Italy (+9,6%)
and growth of Far East and Key Accounts channel. In terms of brands the performance was driven by TF (+22%),
TB (+64%), MB (+30%), BA (+1.0m), GU (+12,%) and EZ launched in the first quarter 2015 (+4m).
• Net Sales @ constant FX +€5.4m or +5.5% vs. PY.
• GM% in 2015 was 40bps below PY, mainly due to a price/volume effect. The selectively reduce prices for certain
product lines was however more than balanced by a corresponding increase in the volumes, especially in Domestic
and Key Accounts Channels, which also triggered a positive variance in the brand mix.
• EBITDA Reported in 2014 is €9,0m vs. €9.8m last year (respectively 7,9% vs. 9.9% of Net sales).
• EBITDA Adjusted, excluding one-off items, would be 13.2% (or €15.2m) vs. 11,6% last year (or € 11.4m).
• Net Financial Costs of €1.4m include €4,2m for Bond interests accruals. Financials also include positive unrealized
exchange differences on the loan from Marcolin S.p.A. to Marcolin USA Corp.
8
YTD Q1 P&L Executive Summary
Consolidated Profit & Loss
9 9
Key financials: YTD Q1
YTD March
(EURm)Actual 15
Reported
Actual 15
Reported %NS
Actual 14
Reported
Actual 14
Reported %NS
Net sales 114,9 100,0% 98,7 100,0%
Cost of sales (46,6) -40,6% (39,7) -40,2%
-- Gross Margin 68,3 59,4% 59,0 59,8%
Selling and marketing costs (53,4) -46,4% (44,6) -45,2%
General and administrative expenses (9,9) -8,6% (7,8) -7,9%
Other operating income and expenses 0,9 0,8% 0,8 0,8%
Effects of accounting for associates 0,0 0,0% 0,2 0,2%
-- OPERATING PROFIT (EBIT) 6,0 5,2% 7,5 7,6%
Net finance costs 1,4 1,2% (5,1) -5,2%
-- Profit before taxes 7,4 6,4% 2,3 2,4%
Income tax expense (3,2) -2,8% (2,1) -2,1%
-- Net Result 4,2 3,7% 0,3 0,3%
-- EBITDA 9,0 7,9% 9,8 9,9%
-- EBITDA ADJUSTED 15,2 13,2% 11,4 11,6%
• Net Trade Receivables: compared to Dec 14, the increase of €20.6m is explained by the higher sales and
particularly by the acceleration of the business at the end of the first quarter of 2015, due to a concentration of
deliveries. In the period total consolidated DSO index is under control and increased by 5 days.
• Inventory: compared to Dec 14 has risen by €9,3m, mostly due to improve customer service aimed at reducing
delivery time, and to investing in supplies of continuing products (to be “never out of stock”). It has been also
impacted by the discontinuity represented new brands, particularly Zegna and Pucci, which have been recently
launched.
• Payables: strongly influenced by seasonality the concentration of payments of supply in the first quarter of the
year, Trade Payables are substantially stable at the end of March, despite the turnover increase.
• Net Financial Position: March 2015 increased from €196.1m (Dec 14) to €220.2m, with a change of €24.1m mostly
due to TWC, as detailed in the consolidated cash flow statement.
10
B/S Executive Summary
Consolidated Balance Sheet
11
Key financials: Q1
2015 and 2014 are Reported
Balance Sheet (EURm) Mar-15 Dec-14 Change vs Dec
Net trade receivables 87,5 66,9 20,6
Inventory 109,4 100,1 9,3
Payables to suppliers (102,4) (102,3) (0,1)
TRADE WORKING CAPITAL 94,5 64,6 29,9
Other receivables 15,6 14,1 1,5
Other payables (37,9) (31,0) (7,0)
NET WORKING CAPITAL 72,2 47,8 24,4
Other receivables - medium/long term 39,1 39,4 (0,3)
Equity investments 2,1 1,9 0,2
Net tangible assets 26,3 24,7 1,6
Net intangible assets 38,1 37,2 0,8
Goodwill 289,2 278,0 11,2
FIXED ASSETS 394,7 381,1 13,6
Funds and reserves (10,4) (10,0) (0,4)
NET INVESTED CAPITAL 456,4 418,9 37,6
Financial debts - short term 53,1 41,4 11,7
Financial debts - medium/long term 201,1 199,2 1,9
FINANCIAL POSITION 254,1 240,5 13,6
Other current financial (28,4) (39,0) 10,6
Other non current financial (5,5) (5,5) (0,0)
NET FINANCIAL POSITION 220,2 196,1 24,2
NET EQUITY 236,2 222,8 13,4
COVERAGE OF NIC 456,4 418,9 37,6
Net Financial Position
12
Key financials: Q1
1
2
(EURm) March 2015 December 2014
Short Term borrowings 53,1 41,4
Medium Long Term borrowings 208,8 207,2
Gross borrowings 261,9 248,6
Cash and cash equivalents 27,4 36,9
Financial receivables current 1,0 2,0
Financial receivables non current 5,5 5,5
Reported Net indebtedness befor Amortized Fees 228,0 204,1
Bond amortized fees (7,7) (8,1)
Reported Net indebtedness after Amortized Fees 220,2 196,1
Revolving Credit Facility 20,0 20,0
Short term borrowings from Banks 19,4 15,0
M/L Term Loan - Current 2,2 1,3
Vendor Loan (HVHC) - Short Term 1,9 1,7
Bond accrued interests 6,5 2,3
Financial leasing VIVA 1,1 0,9
Other 1,9 0,2
Short Term gross borrowing 53,1 41,4
Senior Secured bonds 200,0 200,0
M/L Term Loan - Non Current 5,1 3,8
Vendor Loan (HVHC) - Long Term 2,4 2,1
Financial leasing VIVA 1,2 1,3
Other 0,1 0,1
Medium Long Term gross borrowing 208,8 207,2
2015 and 2014 are Reported
Consolidated Cash Flow Statement
13
Key financials: Q1
(EURm) March 2015 December 2014
Operating activities
Profit before income tax expense 7,4 7,1
Depreciation, amortization and impairments 2,8 8,6
Accruals to provisions/ other non cash items 0,5 (5,0)
CF from operating activities before changes in WC, tax and int. 10,7 10,7
Movements in working capital (27,7) (3,8)
Income taxes paid (0,1) (3,5)
Interest paid (0,4) (17,9)
Net cash flows provided by operating activities (17,4) (14,4)
Investing activities
(Purchase) of property, plant and equipment (2,4) (6,2)
Proceeds from the sale of property, plant and equipment 0,0 1,1
(Purchase) of intangible assets (0,6) (7,4)
(Acquisition) of investment - Marcolin e Viva 0,0 0,0
Net cash (used in) investing activities (3,0) (12,5)
Adjustments to other non-cash items 0,5 (4,6)
Financing activities
Net proceeds from/(repayments of) borrowings 8,9 26,1
Other cash flows from financing activities 0,0 0,0
Net cash from/(used in) financing activities 8,9 26,1
Net increase/(decrease) in cash and cash equivalents (11,1) (5,3)
Effect of foreign exchange rate changes 1,5 3,7
Cash and cash equivalents at beginning of period 36,9 38,5
Cash and cash equivalents at end of period 27,4 36,9
2015 and 2014 are Reported
14
At a glance
Key consolidated financials: LTM
Viva Integration Project
Agenda
Appendix
Key consolidated financials: Q1 2015
Revenues Analisys by market destination
Europe million eur Row ASIA North america million eur million eur million eur
15
1,3696 1,1261 Ex rate EUR/USD
+2.0%
+0.5% +8.9%
+7.2%
+2.2% +3.8%
Key financials: LTM
+31.7% +13.1%
As of March, 31st Full Year
2015 Q1 % 2014 Q1 % 2015 LTM % 2014 %
Europe 32,7 28,4% 32,0 32,5% 131,1 34,6% 130,4 36,0%
North America 52,2 45,4% 39,6 40,2% 152,7 40,4% 140,2 38,7%
Asia 10,0 8,7% 9,4 9,5% 31,4 8,3% 30,7 8,5%
Rest of World 20,0 17,4% 17,7 17,9% 63,2 16,7% 60,8 16,8%
Total 114,9 100,0% 98,7 100,0% 378,3 100,0% 362,1 100,0%
Total @ constant FX (€ Mln) 104,1change vs. PY 5,5%
in € Mln, except percentages in € Mln, except percentages
16
EBITDA REPORTED EBITDA ADJUSTED *
7,6%
ADJ RUN-RATE EBITDA **
% 2015 LTM on net sales
12.6% % 2015 LTM on net sales
8,1% in 2014 13.6%
% 2015 LTM on net sales
12,1% in 2014 13,9% in 2014
* excluding one-offs * including synergies
Ebitda performance – run rate ebitda post synergies (million eur)
Key financials: LTM
2015 MARCH LTM FY 2014 2014 MARCH LTM
NET SALES 378,3 362,1 346,3
% vs. PY 4,5% 0,0
EBITDA 28,6 29,4 28,1Adjustment 19,0 14,4 9,1
47,6 43,8 37,2
Management Fees 0,0 0,0 1,3Germany J/V 0,0 0,0 0,4
EBITDA ADJUSTED 47,6 43,8 38,9Synergies 3,9 6,4 8,5
ADJ RUN-RATE EBITDA 51,6 50,3 47,4
EBITDA ADJ % on Net sales 12,59% 12,10% 11,22%
EBITDA ADJ RR % on Net sales 13,63% 13,88% 13,68%
in € Mln, except percentages
CONSOLIDATED
17
At a glance
Key consolidated financials: LTM
Viva Integration Project
Agenda
Appendix
Key consolidated financials: Q1 2015
Integration Plan
18 18
Viva Integration
TOTAL
(*)
18 months
6 months
3 m
3 m
2014 2015
3 m
6 months
3 m
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
US
UK
France
Hong
Kong
Brazil
Canada
Germany
Integration Updates
19 19
Viva Integration
TOTAL
(*)
2014 2015
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
US
UK
France
Hong
Kong
Brazil
Canada
Germany
15 months
6 months
4 months
3 m
3 m
3 m
Distr.
15 months
Synergies & OTC
20
Synergies 2014 & 2015
One Time Costs 2014 & 2015
Viva Integration
in € Mln Original Budget Realized FY 2014 Estimation FY 2015 Realized Q1 2015 To Go
US 6,1 3,0 6,6 2,1 1,5
UK 1,0 0,5 2,0 0,4 1,1
France 0,8 - 0,9 0,9
Brazil 0,4 - 0,4 0,4
Hong Kong 0,2 0,1 0,2 0,1 -
Total Sinergies 8,5 3,6 10,0 2,5 3,9
in € Mln Original Budget Spent FY 2014 New Estimation Q1 2015 To Go
US 6,4 6,3 9,4 2,7 0,4
UK 0,9 1,4 1,4 - -
France 1,0 0,9 2,3 1,3 0,2
Brazil 0,4 0,5 0,5 - -
Hong Kong 0,3 0,3 0,3 - -
Total OTC 9,0 9,4 14,0 4,0 0,6
21
At a glance
Key consolidated financials: LTM
Viva Integration Project
Agenda
Appendix
Key consolidated financials: Q1 2015
Consolidated Adjusted Ebitda
22
Appendix
in € Mln, except percentages YTD Q1 2015 YTD Q1 2014
EBITDA pre-adjustment 9,0 9,8
Ordinary costs of discontinued Arizona operations 2,1 -
Pro-Forma EBITDA 11,1 9,8
Senior management changes - 0,6
Cost related to VIVA Integration 4,0 1,1
Other 0,1 -
Total adlustments 4,1 1,6
EBITDA ADJUSTED 15,2 11,4
Net Sales 114,9 98,7
% on Net Sales 13,25% 11,55%
in € Mln, except percentages LTM 2015 FY 2014
EBITDA pre-adjustment 28,6 29,4
Ordinary costs of discontinued Arizona operations 2,1 -
Pro-Forma EBITDA 30,7 29,4
Senior management changes 1,5 2,0
Cost related to VIVA Integration 12,3 9,4
Other 3,1 3,0
Total adlustments 16,9 14,4
EBITDA ADJUSTED 47,6 43,8
Net Sales 378,3 362,1
% on Net Sales 12,59% 12,10%
Investor relation
Marcolin Contacts:
Massimo Stefanello
CFO and COO
+39 0437 777111
Alessandra Sartor
+39 0437 777204
23
